Biotron Limited Stock Return On Equity
| BITRF Stock | USD 0.06 0.00 0.00% |
Biotron Limited fundamentals help investors to digest information that contributes to Biotron's financial success or failures. It also enables traders to predict the movement of Biotron Pink Sheet. The fundamental analysis module provides a way to measure Biotron's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotron pink sheet.
Biotron |
Biotron Limited Company Return On Equity Analysis
Biotron's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Biotron Return On Equity | -1.12 |
Most of Biotron's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotron Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Biotron Limited has a Return On Equity of -1.1224. This is 95.32% lower than that of the Healthcare sector and 96.92% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Biotron Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotron's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Biotron could also be used in its relative valuation, which is a method of valuing Biotron by comparing valuation metrics of similar companies.Biotron is currently under evaluation in return on equity category among related companies.
Biotron Fundamentals
| Return On Equity | -1.12 | |||
| Return On Asset | -0.56 | |||
| Profit Margin | (1.78) % | |||
| Operating Margin | (1.78) % | |||
| Current Valuation | 15.31 M | |||
| Shares Outstanding | 901.94 M | |||
| Shares Owned By Insiders | 14.13 % | |||
| Price To Earning | (3.04) X | |||
| Price To Book | 23.61 X | |||
| Price To Sales | 11.17 X | |||
| Revenue | 1.56 M | |||
| Gross Profit | 1.56 M | |||
| EBITDA | (2.73 M) | |||
| Net Income | (2.78 M) | |||
| Cash And Equivalents | 1.74 M | |||
| Total Debt | 77.24 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 2.35 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (2.44 M) | |||
| Earnings Per Share | (0) X | |||
| Number Of Employees | 10 | |||
| Beta | -1.2 | |||
| Market Capitalization | 18.67 M | |||
| Total Asset | 1.91 M | |||
| Retained Earnings | (37 M) | |||
| Working Capital | 3 M | |||
| Current Asset | 3 M | |||
| Net Asset | 1.91 M |
About Biotron Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotron Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotron Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotron in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotron's short interest history, or implied volatility extrapolated from Biotron options trading.
Pair Trading with Biotron
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will appreciate offsetting losses from the drop in the long position's value.Moving against Biotron Pink Sheet
| 0.63 | NVO | Novo Nordisk AS Sell-off Trend | PairCorr |
| 0.63 | NONOF | Novo Nordisk AS | PairCorr |
| 0.6 | AXP | American Express Buyout Trend | PairCorr |
| 0.5 | NSFDF | NXT Energy Solutions | PairCorr |
| 0.47 | REGN | Regeneron Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Biotron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotron Limited to buy it.
The correlation of Biotron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotron Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotron Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Biotron Pink Sheet analysis
When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |